Windsor skin care products provider Scapa Healthcare said Thursday it has agreed to acquire an England-based maker of wound care products.
Scapa said acquiring Systagenix, and its 335,000-square-foot manufacturing facility, will “significantly” add to the Windsor company’s wound care footprint. Financial terms were not disclosed for the deal expected to be completed in October …. read more